Close

Rating History for Karyopharm Therapeutics (KPTI) by RBC Capital

More Stocks Rated by RBC Capital | Latest Ratings for KPTI
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
11/3/2023 Brian Abrahams Maintain Outperform
(N/A)		 3.00
(4.00)		  
 		   Details